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Ovarian follicular development is dependent on the actions and interactions of the pituitary gonado-
tropins, FSH and LH, and the ovarian steroid hormone, estradiol. Agents which might block the effects
ofthese hormones would increase follicular atresia and reduce fertility. In addition, any substance toxic
to the oocyte and its normal pattern ofgrowth and meiosis would lead to reduced numbers ofoocytes and
follicles and impairedfertility. Autoimmunediseases maybe onemajorcauseofpremature ovarianfailure,
and such diseases might be triggered by toxic external stimuli.
The ovarian follicle consists of three cell types: the
germ cell (or oocyte), granulosa cells and thecal endo-
crine cells. The growth, maturation and differentiation
of each cell type is required for successful ovulation of
a fertilizable ovum and formation of a corpus luteum.
Implantation of a fertilized egg subsequently requires
the maintenance of a functional corpus luteum.
Interruption of the events leading to follicular ovu-
lation and luteinization or successful maturation ofooc-
ytes can occur at many stages. The hypothalamic-hy-
pophyseal-gonadal feedback system itself selects only
a few follicles for ovulation. For example, the human
ovary contains approximately two million eggs at birth.
However, during the reproductively active years of
women only 480 eggs ever ovulate (1). In fact, 80% of
the oocytes and follicles contained in the ovary at birth
have been lost (degenerate) before the first ovulation
ever occurs! With so many follicles degenerating or be-
coming atretic and so few beingselected, itisimportant
to know how this stringent biological selection process
works and which steps might be most sensitive to toxic
external stimuli.
Three major processes which occur during the life
spanofafollicle, and whichmightbe susceptible totoxic
substances include: mitosis of oogonia and granulosa
cells occurring at specific stages of follicular growth;
meiosis of oogonia to form oocytes; and differentiation
of granulosa cells and theca cells permitting them to
respond to the LH surge and ovulate. These three pro-
cesses occurduringthelifecycle ofafollicle asdescribed
below (Fig. 1).
Follicle Formation
Formation of follicles occurs during fetal life (in the
human) or immediately after birth (as in the rat). As
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FIGURE 1. Formation and maturation ofan ovarian follicle: cellular
and hormonal events.
germ cells invade the undifferentiated ovary, they are
undergoingmitosis and populate this tissue as ifit were
a nest. Subsequently the germ cells enter the prophase
of meiosis and other cells within the ovary begin to
surround each oocyte. The ovarian cells which are in
direct contact with the egg are called granulosa cells.
In the "resting" or primordial (nongrowing) follicles,
these granulosa cells appear flat. Follicles can remain
embedded in the ovary like this for as long as 55 years!
Agents which might inhibit the migratory behavior of
oogonia as they move from the yolk sac via the blood
stream to ovary would prevent fertility. Such agents
would have to pass the fetal-placental blood barrier.
Agents, such as irradiation, which damage cells inJ. S. RICHARDS
meiosis could reduce fertility by causing meiotic germ
cellstodie (1). Becausemanyofthegermcells are dying
atthis stage "normally," ifwe knewthe reasons forthis
normal loss we might be in a position to reverse it.
Lastly, oocytes which remain in the resting phase of
meiosis for 50 years or more are often associated with
increased chromosomal abnormalities (2). The causes
are unknown.
Initiation of Follicle Growth
Initiation offollicular growth occurs continuously un-
til menopause. That is, each day from birth to meno-
pause a certain number of follicles begin to grow.
Growth initiation is characterized by three events: the
oocyte begins to enlarge; the granulosa cells change
from their flattened form to a rounded configuration;
and the complex protein/carbohydrate extracellularma-
trix between the granulosa cells and oocytes, called the
zona pellucida, appears. This first stage ofgrowth typ-
ifies the class offollicles known as primary follicles. The
hornones or factors which trigger the initiation of
growth of any given follicle on a given day are as yet
unknown. The pituitary hormones, FSH and LH, ap-
pear not to be involved in this first step. For lack of a
better explanation, some biologists have said this pro-
cess occurs by chance. However, as more is learned
about the biology and molecularbiology ofdevelopment
in other systems, the secretto thisfirststepoffollicular
growthmaybeunveiled. Whenthissecretisuncovered,
it should be possible to inhibit or speed up this process
for the specific needs offertility control.
Follicular Growth
Growth of the ovarian follicle is associated with five
events: the oocyte continues to grow; the number of
layers ofgranulosa cells increases; the basal lamina, an
extracellular matrix external to the outer layerofgran-
ulosa cells is formed; the endocrine thecal cells organize
aroundthebasallamina; andthefluidfilledcavity, called
an antrum, appears.
The multiple layers ofgranulosa cells within the fol-
licle are formed by theprogressive increase inthe num-
ber of granulosa cells within the follicle. The most el-
egant demonstration of their remarkable rate of cell
division has been provided by the studies and photo-
graphs of Hirshfield (3). This mitotic activity is main-
tained throughout follicular growth and ceases only
when either luteinization or atresia occurs.
Agents which inhibit cell division would inhibit gran-
ulosacellgrowthand cause anincrease infollicularatre-
sia. Because the growth of the ovarian follicle during
thistime isdependent onFSHand LH, anyagentblock-
ing either the synthesis or action ofthe gonadotropins
would cause an increase in atresia and a decrease in
fertility. Some agents which have been shown to in-
crease atresia are GnRH (4), EGF, and high concen-
trations ofandrogens (5). Each ofthese has been shown
to impair the response of granulosa cells to FSH, pri-
marily by altering the synthesis or intracellular action
of cyclic AMP (cAMP). The stages of follicular growth
which are most sensitive to these inhibitors remains to
be clearly defined.
Follicular Differentiation
Differentiation is the hallmark of those few ovarian
follicles which successfully develop to a stage capable
of undergoing ovulation. Remember this select group
includes only 480 out of the two million follicles con-
tained in the human ovary at birth. What regulates this
stringent biological selection process? If all follicles
within the ovary are exposed tothe same cyclic changes
in FSH and LH, why do some ovulate whereas others
do not? Why do some follicles become atretic whereas
others continue to grow?
The key to the development of a follicle which suc-
ceeds in ovulating lies in the ability of that follicle to
acquire new functional capabilities in response to the
same signals, FSH and LH. Yet, one might ask how
can the same hormone (FSH) acting on granulosa cells
via the same receptor (RFSH) cause different effects
dependingonwhetherthegranulosacellsarefromsmall
follicles or large follicles? Likewise, how can LH acting
on theca cells elicit different effects in small follicles
versus large follicles? These are not only intriguing
questions, but also appear to be the secret of how the
ovarymaintains continuous growth ofsmallfolliclesand
at the same time selects specific follicles for ovulation
(5).
To summarize the results of many experiments we
can say that the tonic secretion of FSH and LH main-
tains the growth of follicles to the small antral stage
andasubtleincreaseinLH(orincreasedresponsiveness
to LH) is required for the final stages of follicular
growth. The increase in LH stimulates the conversion
ofprogesterone to androstenedione by the 17a-hydrox-
ylase/C17-20 lyase enzyme in theca cells. The androgens
are then converted to estradiol in granulosa cells. Es-
tradiol acting with FSH (or cAMP) is obligatory for
regulating the differentiation ofgranulosa cells includ-
ingtheincreased cellularcontent ofLHreceptors, FSH
receptors, aromatase activity, cholesterol side chain
cleavage, cytochrome P-450 (P-450CSCC) and prosta-
glandin synthetase (5,6). The last ofthese regulates the
synthesis ofprostaglandins which are increased by the
LH surgeandarethenobligatoryforovulationtooccur.
The essence ofthis briefoverview is that the differ-
entiation of theca cells (increased androgen synthesis)
determines which follicles will gain the substrates nec-
essary for estradiol synthesis. Only those follicles ca-
pable of producing estradiol become preovulatory fol-
licles (Fig. 2) (5,6). Thus, any agent which inhibits
either theca cell function (ability to synthesize andro-
gens) or granulosa cells function (synthesis and action
of estradiol) will cause atresia. Furthermore, because
both LH and FSH act via cAMP, agents which alter
gonadotropin receptor content or the functional cou-
160OVARIAN FOLLICULAR GROWTH 161
PREOVULATORY FOLLICLE
FSH
RFSH
LH- RLN 1 ATP LR
LH-RLN cAMP RN
RLM cAMP-BP ........................
T-_T AROMATASE E RE
THECA GRANULOSA
SMALL ANTRAL FOLLICLE ATRETIC FOLLICLE
FSH FSH
. FSm RFSH
LH-RLM. ATP LH-RL ATP
cAMP cAMP .
cAMP-BP
AROMATASE -RE AROMATASE T--THEC GRANULE T-H 7 E
THECA GRANULOSA THECA GRANULOSA
FIGURE 2. Roles of FSH, LH, and estradiol on follicular cell func-
tion.
pling ofthe receptor to adenylate cyclase will also cause
atresia and lowered fertility.
Premature ovarian failure can also be linked to the
immune system. For example, fetal thymectomy in
monkeys (7) and mice (8,9) leads to abnormal ovarian
differentiation in adult animals. Exposure ofanimals to
the glycoprotein components ofthe zona pellucida leads
to the synthesis of antibodies and the dramatic loss of
oocytes from the ovary (10). Thus, premature meno-
pausecould belinkedtoanautoimmune diseaseinwhich
antibodies to the zona pellucida or other structures of
the follicle could result in the loss of follicles.
Atresia as it occurs naturally is a poorly understood
process but plays a key role in fertility (11). Atresia
may result fromgonadotropin concentrations which are
too low or may be stimulated by an endogenous antag-
onist. As more and more peptides within the ovary are
characterized it is possible that a specific atretogenic
factor will be identified.
In summary, external agents may interfere with fer-
tility at the ovarian level by acting at many sites to: (1)
decrease the concentrations of gonadotropins, (2) de-
stroy oocytes, (3) cause autoimmune mechanisms to op-
erate, (4) increase antigonadal peptides, (5) inhibit the
actions of LH and FSH (cAMP), (6) inhibit the action
ofestradiol, (7) prevent luteinization, (8) increase syn-
thesis luteolytic factors, and (9) altergene transcription
and prevent differentiation.
The tools to measure many of the functional aspects
ofgranulosa and theca cell differentiation (such as hor-
mone receptors) are now available. Recombinant DNA
technology is also going to provide new and sensitive
tools with which to identify how various agents alter
ovarian cell function (12-15). These tools, applied tothe
toxicology of the ovary, could provide important new
insight into the control offollicular and luteal cell func-
tion.
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